Carolyn R. Bertozzi - 22 Oct 2026 Form 3 Insider Report for Lycia Therapeutics, Inc.

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
22 Oct 2026, 19:23:08 UTC
Prior SEC filing
18 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Carolyn Bertozzi
Filing notes and source

Key filing fact

Carolyn R. Bertozzi filed Form 3 for Lycia Therapeutics, Inc. on 22 Oct 2026.

Key facts

  • This page summarizes Carolyn R. Bertozzi's Form 3 filing for Lycia Therapeutics, Inc..
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 22 Oct 2026, 19:23.

Change

  • Previous filing in this sequence was filed on 18 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001698766 Primary reporting owner

Bertozzi Carolyn R

Relationship
10%+ Owner
Address
C/O LYCIA THERAPEUTICS, INC., 400 EAST JAMIE COURT, SUITE 200, SOUTH SAN FRANCISCO
Signature
/s/ Carolyn Bertozzi
Signature date
22 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

No ticker holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
904,821
Date
22 Oct 2026
Ownership
Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .